Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexalin Technology (NXL) EBT Margin (2021 - 2025)

Nexalin Technology has reported EBT Margin over the past 5 years, most recently at 1382.56% for Q4 2025.

  • Quarterly results put EBT Margin at 1382.56% for Q4 2025, up 904268.0% from a year ago — trailing twelve months through Dec 2025 was 2725.42% (up 178619.0% YoY), and the annual figure for FY2025 was 2725.42%, up 178619.0%.
  • EBT Margin for Q4 2025 was 1382.56% at Nexalin Technology, up from 12542.35% in the prior quarter.
  • Over the last five years, EBT Margin for NXL hit a ceiling of 55.68% in Q3 2022 and a floor of 12542.35% in Q3 2025.
  • Median EBT Margin over the past 5 years was 2466.07% (2021), compared with a mean of 3909.21%.
  • Biggest five-year swings in EBT Margin: plummeted -947108bps in 2023 and later surged 904268bps in 2025.
  • Nexalin Technology's EBT Margin stood at 2483.14% in 2021, then rose by 23bps to 1907.96% in 2022, then plummeted by -99bps to 3801.47% in 2023, then plummeted by -174bps to 10425.24% in 2024, then surged by 87bps to 1382.56% in 2025.
  • The last three reported values for EBT Margin were 1382.56% (Q4 2025), 12542.35% (Q3 2025), and 2239.74% (Q2 2025) per Business Quant data.